North East and North Cumbria
ICS Formulary
ICS Formulary
2 Cardiovascular system
02-09 Antiplatelet drugs
| Clopidogrel |
|
Formulary
|
|
 MHRA Drug Safety Update (December 2013): Clopidogrel - risk of acquired haemophilia with clopidogrel NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events |
|
| Dipyridamole |
|
Formulary
|
|
|
NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events |
|
|
unlicensed.| Prasugrel |
|
Formulary
|
|
|
MHRA Drug Safety Update (January 2014): Prasugrel (Efient): increased risk of bleeding – advice around timing of loading dose for prasugrel NICE TA317 (replaces TA182): Acute coronary syndrome - prasugrel |
|
| Ticagrelor |
|
Formulary
|
|
|
NICE TA236: Ticagrelor for the treatment of acute coronary syndromes NICE TA420: Ticagrelor for preventing atherothrombotic events after myocardial infarction |
|
|
| Aspirin 500mg in 5ml injection |
|
Formulary
|
|
|
| Clopidogrel 75mg in 5ml suspension |
|
Formulary
|
|
|
|
Links
- Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
- County Durham and Darlington DVT Pathway Information
- County Durham and Tees Valley Prescribing Guideline for the Use of Anticoagulants in Non-Valvular Atrial Fibrillation
- MHRA Drug Safety Update (December 2013): Clopidogrel - risk of acquired haemophilia with clopidogrel
- MHRA Drug Safety Update (January 2014): Prasugrel (Efient): increased risk of bleeding – advice around timing of loading dose for prasugrel
- NICE CG180: Atrial Fibrillation (NICE CG180 - replaces CG36)
- NICE CG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE NG148: Acute kidney injury: prevention, detection and management
- NICE NG185 Acute coronary syndromes
- NICE NG191: COVID-19 rapid guideline: managing COVID-19
- NICE TA210: Clopidogrel and dipyridamole for prevention of occlusive vascular events
- NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
- NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
- NICE TA236: Ticagrelor for the treatment of acute coronary syndromes
- NICE TA317 (replaces TA182): Acute coronary syndrome - prasugrel
- NICE TA420: Ticagrelor for preventing atherothrombotic events after myocardial infarction
- North Cumbria - Cardiovascular workplan 2022
North of Tyne and Gateshead - Guidelines for the anti-platelet treatment for prevention of cardiovascular events in patients with or at risk of vascular disease- South Tees Hospitals Cardiology drug prescribing guidelines & formulary